BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herbelet S, De Paepe B, De Bleecker JL. Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5. Int J Mol Sci 2020;21:E9225. [PMID: 33287327 DOI: 10.3390/ijms21239225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kosac A, Pesovic J, Radenkovic L, Brkusanin M, Radovanovic N, Djurisic M, Radivojevic D, Mladenovic J, Ostojic S, Kovacevic G, Kravljanac R, Savic Pavicevic D, Milic Rasic V. LTBP4, SPP1, and CD40 Variants: Genetic Modifiers of Duchenne Muscular Dystrophy Analyzed in Serbian Patients. Genes 2022;13:1385. [DOI: 10.3390/genes13081385] [Reference Citation Analysis]
2 Herbelet S, Merckx C, De Paepe B. The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target. Biomedicines 2021;9:350. [PMID: 33808305 DOI: 10.3390/biomedicines9040350] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Peristeri E, Dardiotis E. Editorial for Special Issue "Genetic Basis and Epidemiology of Myopathies". Int J Mol Sci 2021;22:2152. [PMID: 33671495 DOI: 10.3390/ijms22042152] [Reference Citation Analysis]